Thousands of men battling prostate cancer are set to gain access to a life-extending drug on the NHS following a significant ...

Thousands of men with prostate cancer will be offered a life-extending drug on the NHS within weeks. For the first time patients whose prostate cancer has not spread will be able to receive the drug ...

A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks, after a ...

University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to Alessa Therapeutics for its lead product ...

Study shows boosting diet with supplements could halt prostate tumour growth and help men avoid unnecessary surgery, chemo or ...

Ernie Strauss and Ronald Wakefield, who met through the patient navigation program of Northside Hospital, have built a ...

“Me encontraron càncer en la pròstata,” my father told me. “They found cancer in my prostate.” As a cancer researcher who knows very well about the high incidence and decreased survival rates of ...

Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a side effect so debilitating that patients often refuse the life-saving ...

A former prostate cancer patient who got the all-clear said taking part in a trial that cut his radiotherapy treatments ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...